| Literature DB >> 33263350 |
Noemi Giannetta1, Giuseppe Campagna2, Flavio Di Muzio3, Emanuele Di Simone4, Sara Dionisi5, Marco Di Muzio6.
Abstract
BACKGROUND AND AIM: Electrocardiogram (ECG) is considered the most used diagnostic tool to identify many cardiological disease and conditions that require the monitoring and recording of heart's electric activity. The aim of this study is the validation and application of a web-survey, addressed to nursing students and nurses, in order to evaluate the degree of accuracy and the knowledge on the correct positioning of the 12-leads ECG.Entities:
Year: 2020 PMID: 33263350 PMCID: PMC8023103 DOI: 10.23750/abm.v91i12-S.10349
Source DB: PubMed Journal: Acta Biomed ISSN: 0392-4203
Items of the instrument
Demographics detail of nurses and nursing students
| n(%) | |
| 32.01±9.63 | |
| 149 (30.79) | |
| 335 (69.21) | |
| 97 (20.04) | |
| 387 (79.96) | |
| 229 (47.81) | |
| 172 (35.91) | |
| 78 (16.28) | |
| < | 55 (13.96) |
| 91 (26.84) | |
| 58 (23.39) | |
| 74 (38.95) | |
| 116 (61.06) | |
| 10 (2.07) | |
| 17 (3.51) | |
| 57 (11.78) | |
| 9 (1.86) | |
| 391 (80.78) | |
| 11 (2.27) | |
| 28 (5.78) | |
| 91 (18.80) | |
| 199 (41.12) | |
| 155 (32.02) | |
| 46 (9.50) | |
| 59 (12.19) | |
| 108 (22.31) | |
| 157 (32.44) | |
| 114 (23.55) | |
| 23 (4.75) | |
| 50 (10.33) | |
| 84 (17.35) | |
| 156 (32.23) | |
| 171 (35.33) | |
| 63 (13.02) | |
| 57 (11.78) | |
| 57 (11.78) | |
| 112 (23.14) | |
| 1 (0.21) | |
| 194 (40.08) | |
| 201 (41.53) | |
| 122 (25.21) | |
| 51 (10.54) | |
| 110 (22.72) |
*mean±SD
aNumber of responders to the question: 479
bNumber of responders to the question: 394
Nursing staff and nursing students knowledge
| Knowledge | ||
| N | 484 | |
| 6,90 | ||
| ,097 | ||
| 7,00 | ||
| 2,125 | ||
Multivariate logistic regression for theoretical knowledge
| Characteristic | OR (95%CI) | p | p-adjusted |
| 0.96 (0.94-0.98) | |||
| 0.48 (0.25-0.92) | 0.0265 | 0.053 | |
| 0.24 (0.12-0.47) | <.0001 | ||
| 1.73 (0.30-9.97) | 0.5405 | 0.61 | |
| 0.86 (0.28-2.63) | 0.7863 | 0.79 | |
| 0.49 (0.29-0.83) | 0.0079 | ||
| 3.58 (0.65-19.55) | 0.1412 | 0.23 | |
| 1.77 (0.63-4.98) | 0.2776 | 0.40 | |
| 7.32 (1.31-40.87) | 0.0232 | 0.053 | |
| 3.63 (1.26-10.44) | 0.0169 | 0.053 | |
| 0.49 (0.07-3.42) | 0.4761 | 0.59 | |
| Characteristic | |||
| 0.95 (0.93-0.98) | |||
| Characteristic | |||
| 0.76 (0.41-.41) | 0.38 | 0.38 | |
| 0.40 (0.20-0.79) | 0.009 | ||
| 1.92 (0.89-4.11) | 0.09 | 0.13 | |
| 0.89 (0.35-2.29) | 0.82 | 0.82 | |
| 1.21 (0.43-3.42) | 0.72 | 0.80 | |
| 1.74 (0.67-4.52) | 0.26 | 0.43 | |
| 3.97 (1.62-9.73) | 0.003 | ||
| 1.35 (0.54-3.37) | 0.52 | 0.65 | |
| 1.94 (0.85-4.44) | 0.12 | 0.23 | |
| 4.43 (2.08-9.45) | 0.0001 | ||
| 1.44 (0.56-3.68) | 0.45 | 0.64 | |
| 3.28 (1.40-7.71) | 0.006 | ||
| 2.28 (1.09-4.80) | 0.03 | 0.07 | |
| 0.32 (0.15-0.68) | 0.003 | 0.006 | |
| 0.14 (0.06-0.34) | <.0001 | ||
| 10.01 (0.90-111.90) | 0.06 | 0.08 | |
| 2.96 (0.78-11.34) | 0.11 | 0.12 | |
| 0.44 (0.22-0.88) | 0.02 | ||
| 0.03 (0.003-0.35) | 0.005 | ||
| 0.11 (0.03-0.39) | 0.0008 | ||
| 0.11 (0.001-0.16) | 0.0006 | ||
| 0.05 (0.01-0.18) | <.0001 | ||
| 0.30 (0.02-3.74) | 0.35 | 0.35 | |
| 0.26 (0.07-1.00) | 0.05 | 0.15 | |
| 0.52 (0.16-1.73) | 0.29 | 0.41 | |
| 0.69 (0.22-2.17) | 0.52 | 0.58 | |
| 1.38 (0.44-4.35) | 0.58 | 0.58 | |
| 1.97 (0.67-5.81) | 0.22 | 0.36 | |
| 2.61 (0.90-7.53) | 0.08 | 0.15 | |
| 5.22 (1.73-15.76) | 0.003 | ||
| 1.32 (0.63-2.79) | 0.46 | 0.58 | |
| 2.65 (1.16-6.03) | 0.02 | 0.10 | |
| 2.00 (0.96-4.16) | 0.06 | 0.15 | |
aOnly p in bold are statistically significant
bThe model includes the independent variables: job, “where do you study/work?”, years’ work experience, years of studies, importance of a lesson, importance of practice, the most recent training activity, mean of n. ECG/week
cThe model includes the independent variables: job, “where do you study/work?”, years’ work experience, years of studies, 12-lead ECG knowledge, importance of a lesson, importance of practice, the most recent training activity, mean of n. ECG/week
dThe model includes the independent variables: age, job, years of studies, importance of practice, the most recent training activity, mean of n. ECG/week
Nursing staff and nursing students accuracy
| Accuracy | ||
| 484 | ||
| 6,77 | ||
| ,038 | ||
| 7,00 | ||
| ,835 | ||
Multivariate logistic regression for accuracy level
| Characteristic | OR (95%CI) | p |
| 0.94 (0.89 to 0.99) | ||
| 0.07 (0.01 to 0.44) | ||
aOnly p in bold are statistically significant
eThe model includes the independent variables: “where do you study/work?”, years’ work experience, years of studies, 12-lead ECG knowledge, importance of a lesson, importance of practice, the most recent training activity, mean of n. ECG/week
STROBE Statement—checklist of items that should be included in reports of observational studies
| Item No | Recommendation | Page No | |
| 1 | ( | 1-2 | |
| ( | 1-2 | ||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | 3-4 |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses | 3-4 |
| Study design | 4 | Present key elements of study design early in the paper | 4-5 |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | 4-5 |
| 3Participants | 6 | ( | 4-5 |
| ( | |||
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | 4-5 |
| Data sources/ measurement | 8* | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | |
| Bias | 9 | Describe any efforts to address potential sources of bias | - |
| Study size | 10 | Explain how the study size was arrived at | 4-5 |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | - |
| Statistical methods | 12 | ( | 4-5 |
| ( | |||
| ( | |||
| ( | |||
| ( | 4-5 | ||
| Participants | 13* | (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed | 6-9 |
| (b) Give reasons for non-participation at each stage | |||
| (c) Consider use of a flow diagram | |||
| Descriptive data | 14* | (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders | 6-9 |
| (b) Indicate number of participants with missing data for each variable of interest | 6-9 | ||
| (c) | |||
| Outcome data | 15* | ||
| Main results | 16 | ( | 6-9 |
| ( | 6-9 | ||
| ( | 6-9 | ||
| Other analyses | 17 | Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses | 6-9 |
| Key results | 18 | Summarise key results with reference to study objectives | 8-9 |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | 8-9 |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | 8-9 |
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results | 8-9 |
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | 10 |
*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org.